| 期刊論文| 1. | Cheng, Hao-Yuan、Jian, Shu-Wan、Liu, Ding-Ping、Ng, Ta-Chou、Huang, Wan-Ting、Lin, Hsien-Ho(2020)。Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset。JAMA Internal Medicine，180(9)，1156-1163。   | | 2. | Sanche, Steven、Lin, Yen Ting、Xu, Chonggang、Romero-Severson, Ethan、Hengartner, Nick、Ke, Ruian(2020)。High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2。Emerging Infectious Diseases，26(7)，1470-1477。 | | 3. | Lu, R.、Zhao, X.、Li, J.、Niu, P.、Yang, B.、Wu, H.、Wang, W.、Song, H.、Huang, B.、Zhu, N.、Bi, Y.、Ma, X.、Zhan, F.、Wang, L.、Hu, T.、Zhou, H.、Hu, Z.、Zhou, W.、Tan, W.(2020)。Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding。The Lancet，395(10224)，565-574。 | | 4. | Bandyopadhyay, S.、Baticulon, R. E.、Kadhum, M.、Alser, M.、Ojuka, D. K.、Badereddin, Y.、Kamath, A.、Parepalli, S. A.、Brown, G.、Iharchane, S.、Gandino, S.、Markovic-Obiago, Z.、Scott, S.、Manirambona, E.、Machhada, A.、Aggarwal, A.、Benazaize, L.、Ibrahim, M.、Kim, D.、Khundkar, R.(2020)。Infection and mortality of healthcare workers worldwide from COVID-19: A systematic review。BMJ Global Health，5(12)。 | | 5. | Callaway, E.(2020)。The race for coronavirus vaccines: A graphical guide。Nature，580(7805)，576-577。 | | 6. | Coronaviridae Study Group of the International Committee on Taxonomy of Viruses(2020)。The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2。Nature Microbiology，5(4)，536-544。 | | 7. | Galván Casas, C.、Català, A.、Carretero Hernández, G.、Rodríguez-Jiménez, P.、Fernández-Nieto, D.、Rodríguez-Villa Lario, A.、Navarro Fernández, I.、Ruiz-Villaverde, R.、Falkenhain-López, D.、Llamas Velasco, M.、García-Gavín, J.、Baniandrés, O.、González-Cruz, C.、Morillas-Lahuerta, V.、Cubiró, X.、Figueras Nart, I.、Selda-Enriquez, G.、Romaní, J.、Fustà-Novell, X.、García-Doval, I.(2020)。Classification of the cutaneous manifestations of COVID-19: A rapid prospective nationwide consensus study in Spain with 375 cases。The British Journal of Dermatology，183(1)，71-77。 | | 8. | Han, C.、Duan, C.、Zhang, S.、Spiegel, B.、Shi, H.、Wang, W.、Zhang, L.、Lin, R.、Liu, J.、Ding, Z.、Hou, X.(2020)。Digestive symptoms in COVID-19 patients with mild disease severity: Clinical presentation, stool viral RNA testing, and outcomes。The American Journal of Gastroenterol，115(6)，916-923。 | | 9. | Letko, M.、Marzi, A.、Munster, V.(2020)。Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses。Nature Microbiology，5(4)，562-569。 | | 10. | Nishiura, H.、Linton, N. M.、Akhmetzhanov, A. R.(2020)。Serial interval of novel coronavirus (COVID-19) infections。International Journal of Infectious Diseases，93，284-286。 | | 11. | Reiter, E. R.、Coelho, D. H.、Kons, Z. A.、Costanzo, R. M.(2020)。Subjective smell and taste changes during the COVID-19 pandemic: Short term recovery。American Journal of Otolaryngology，41(6)。 | | 12. | Sethuraman, N.、Jeremiah, S. S.、Ryo, A.(2020)。Interpreting diagnostic tests for SARS-CoV-2。The Journal of the American Medical Association，323(22)，2249-2251。 | | 13. | Ong, Sean Wei Xiang、Tan, Y. K.、Chia, P. Y.、Lee, T. H.、Ng, O. T.、Wong, M. S. Y.、Marimuthu, K.(2020)。Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient。JAMA: The Journal of the American Medical Association，323(16)，1610-1612。 | | 14. | Wang, Dawei、Hu, Bo、Hu, Chang、Zhu, Fangfang、Liu, Xing、Zhang, Jing、Peng, Zhiyong、Wang, B.、Xiang, H.、Cheng, Z.、Xiong, Y.、Zhao, Y.、Li, Y.、Wang, X.(2020)。Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China。JAMA: The Journal of the American Medical Association，323(11)，1061-1069。 | 其他| 1. | Siegel, J. D.，Rhinehart, E.，Jackson, M.，Chiarello, L.，The Healthcare Infection Control Practices Advisory Committee(2019)。2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings，https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html。 | | 2. | National Institute for Occupational Safety and Health(2014)。NIOSH fact sheet: The Buddy System，https://www.cdc.gov/vhf/ebola/pdf/buddy-system.pdf。 | | 3. | The Joint Committee on Vaccination and Immunisation(2020)。Independent report joint committee on vaccination and immunisation: Advice on priority groups for COVID-19 vaccination, 30 December 2020，https://www.gov.uk/government/publications/priority-groups-for-coronaviruscovid-19-vaccination-advice-from-the-jcvi-30-december-2020/joint-committee-onvaccination-and-immunisation-advice-onpriority-groups-for-covid-19-vaccination-30-december-2020。 | | 4. | U.S. Food and Drug Administration(2020)。Moderna COVID-19 Vaccine，https://www.fda.gov/emergency-preparednessand-response/coronavirus-disease-2019-covid-19/moderna-covid-19-vaccine。 | | 5. | WHO(20201223)。Coronavirus disease (COVID-19): Vaccines，https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)vaccines?adgroupsurvey={adgroupsurvey}&gclid=Cj0KCQiA0MD_BRCTARIsADXoopYcRtRHcj0mQ1JxFjq2yuvl4Qe7Xpv4_82w1LKXuz7I45Hes00rKlYaAnrhEALw_wcB。 | | 6. | WHO(20201223)。Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages，https://www.who.int/publications/i/item/rational-useof-personal-protective-equipment-forcoronavirus-disease-(covid-19)-andconsiderations-during-severe-shortages。 | |